Recent studies suggest that PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in the Eμ-TCL1 transgenic CLL mouse model [13, 14]. The gene discussed is CD274; the disease is B-cell chronic lymphocytic leukemia.